glp-1 lilly Eli Lilly's Obesity Pill Appears to Work as Well as Injected GLP-1s US approves new oral weight-loss

Once daily vs twice daily dosing Once daily (most common): 500mcg in morning or early afternoon Simplest approach Good for mild-moderate anxiety Consistent baseline coverage Advantages of once daily: Easier to remember Less injection burden Sufficient for most people More sustainable long-term Twice daily (for severe symptoms): Split dose: 250-500mcg morning + 250-500mcg afternoon Total 500-1,000mcg daily Better for severe anxiety or mood instability More consistent coverage When to use twice daily: Severe generalized anxiety Panic disorder Significant mood swings Late-day anxiety worsening Need all-day coverage Best timing for Selank injections Morning injection (most popular): 6-9 AM injection Sets calm tone for day Peak effects during work hours Wears off by evening (good for sleep) Early afternoon: 12-2 PM injection Good if morning anxiety not severe Covers afternoon/evening stress Alternative to morning Split dosing schedule: Morning: 250-500mcg (8 AM) Afternoon: 250-500mcg (2 PM) Never dose after 4-5 PM (can affect sleep in sensitive people) Avoid evening/night injections: Selank isn't sedating but shouldn't be taken late Can interfere with sleep in some people Morning/afternoon better Cycling vs continuous use Continuous use (recommended): Daily injections ongoing No cycling needed for Selank Maintains stable anxiolytic effects Safe for months to years Why continuous is better: Selank isn't downregulating Benefits maintained long-term No tolerance development Stable mood/anxiety control Optional cycling approach: 8-12 weeks on, 2-4 weeks off For very long-term use (1+ years) More psychological than necessary Most people stay on continuously How long to use: Minimum: 4-6 weeks (see full benefits) Common: 3-6 months initially Long-term: Many use 6-12+ months Can use indefinitely with medical supervision See our peptide cycle planning guide and can you cycle different peptides

Exendin-4 differentially modulates essential functions of human dermal fibroblasts under normoglycemic and hyperglycemic conditions

Diabetes Care 21(11):19601966

Either works

1990, 5: 8- Rebouche CJ: Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism

18 Fras, J.P., et al., Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes